U.S. Patent 7647115 was awarded to Ardian, Inc. on 2010-01-12 and describes a “Renal nerve stimulation method and apparatus for treatment of patients.” This patent has been cited 267 times by other U.S. patents which places it in the top 500 cited patents since 2010 according to our law firm research, and makes it of the most innovative medical technology patents in the field of instruments. The abstract states:

A method and apparatus for treatment of heart failure, hypertension and renal failure by stimulating the renal nerve. The goal of therapy is to reduce sympathetic activity of the renal nerve. Therapy is accomplished by at least partially blocking the nerve with drug infusion or electrostimulation. Apparatus can be permanently implanted or catheter based. Link: U.S. Patent 7647115

This patent was originally filed on 2005-06-03 which gives it a processing time of 1684 days, compared to an average processing time of 1742 in the field. Ardian, Inc. has 29 total patents. The first named inventor is Mark Gelfand of New York, NY. The primary examiner was Mark W Bockelman.

Select Patents monitors top medical technology patents and instruments patents which have been allowed and granted worldwide. If you would like legal advice regarding a patent or would like to file a patent go to https://selectpatents.wpengine.com/contact/